Clinical Trial Update: VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial update evaluating venetoclax plus decitabine with a Busulfan/Fludarabine conditioning regimen (Bu2Flu4) versus Bu2Flu5 in elderly patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Drugs mentioned

• BUSULFAN (Busulfan)
• Decitabine (Decitabine)
• Fludarabine (Fludarabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Older Patients, Myeloid Malignancies | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING